| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.23 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.24 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |